ARK Investment Management - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$2,170,625
-29.9%
57,561
-29.5%
0.02%
-15.0%
Q2 2023$3,095,809
+78.5%
81,619
+14.4%
0.02%
+66.7%
Q1 2023$1,734,624
-12.0%
71,325
+5.0%
0.01%
-29.4%
Q4 2022$1,972,164
+7.4%
67,912
+10.8%
0.02%
+30.8%
Q3 2022$1,837,000
-10.3%
61,287
+9.6%
0.01%
+8.3%
Q2 2022$2,049,000
-14.8%
55,940
+0.7%
0.01%
+20.0%
Q1 2022$2,404,000
-2.6%
55,566
+12.8%
0.01%
+42.9%
Q4 2021$2,468,000
-24.2%
49,259
-3.7%
0.01%
-12.5%
Q3 2021$3,256,000
-40.9%
51,167
-33.2%
0.01%
-20.0%
Q2 2021$5,512,000
-4.9%
76,598
-2.6%
0.01%
-16.7%
Q1 2021$5,799,000
+181.9%
78,627
+180.6%
0.01%
+140.0%
Q4 2020$2,057,000
+195.5%
28,021
+120.7%
0.01%
+25.0%
Q3 2020$696,000
-30.7%
12,696
-16.0%
0.00%
-63.6%
Q2 2020$1,005,000
+142.2%
15,114
+123.0%
0.01%
+10.0%
Q1 2020$415,000
+0.2%
6,779
+44.0%
0.01%0.0%
Q4 2019$414,000
-1.4%
4,707
-15.4%
0.01%
+11.1%
Q3 2019$420,000
+2.9%
5,563
+16.5%
0.01%
-10.0%
Q2 2019$408,000
-24.3%
4,776
-4.2%
0.01%
-33.3%
Q1 2019$539,000
+24.2%
4,986
-2.8%
0.02%
-16.7%
Q4 2018$434,000
-6.9%
5,132
+8.2%
0.02%
+28.6%
Q3 2018$466,000
-25.2%
4,743
-11.9%
0.01%
-39.1%
Q2 2018$623,000
+16.2%
5,385
-0.8%
0.02%
-14.8%
Q1 2018$536,000
+117.0%
5,431
+130.5%
0.03%
+35.0%
Q4 2017$247,0002,3560.02%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 640,735$24,1628.90%
Eversept Partners, LP 255,323$9,628,2300.82%
Murchinson Ltd. 103,744$3,912,1860.50%
BRANDES INVESTMENT PARTNERS, LP 472,488$17,817,5220.35%
COWEN AND COMPANY, LLC 69,160$2,608,0230.18%
HARVEST MANAGEMENT LLC 7,106$267,9670.14%
Alpine Global Management, LLC 8,158$307,6380.08%
Inspire Advisors, LLC 10,695$403,3090.07%
Renaissance Technologies 588,800$22,2040.04%
Analyst IMS Investment Management Services Ltd. 13,557$5130.03%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders